Internal Medicine, Gastroenterology · Creve Coeur, MO
NPI
1750495099
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
Specialists in Gastroenterology, 11525 Olde Cabin Road
Creve Coeur, MO, 63141
Phone (314) 997-0554
Groups this clinician bills Medicare through
Medicare paid, 2024
$352K
13,317 services
Medicare patients, 2024
681
Average age 74
Drug cost, 2024
$872K
1,900 prescriptions
Company payments, 2025
$1,288
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Erik P Thyssen was code J3380 (injection, vedolizumab, intravenous, 1 mg), 9,000 times for 15 patients. In total Erik P Thyssen billed 13,317 services in 51 codes, and Medicare paid $352K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 9,000 | 15 | $16.94 | $152K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,050 | 19 | $24.80 | $51K |
| 99214 Office E&M - Established | Office | 366 | 239 | $92.38 | $34K |
| 45385 Colonoscopy - Lesion Removal | Facility | 182 | 181 | $201.17 | $37K |
| 43239 Upper GI Endoscopy | Facility | 143 | 140 | $70.67 | $10K |
| 45380 Lower GI Endoscopy - Other | Facility | 106 | 105 | $97.98 | $10K |
| 99213 Office E&M - Established | Office | 86 | 79 | $56.55 | $4,864 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 75 | 74 | $170.36 | $13K |
| 99204 Office E&M - New | Office | 66 | 66 | $119.65 | $7,897 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 45 | 45 | $168.87 | $7,599 |
| 96413 Chemotherapy Administration | Office | 37 | 20 | $94.13 | $3,483 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 32 | 15 | $36.71 | $1,175 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 31 | 19 | $48.04 | $1,489 |
| 96365 Intravenous Infusion, Hydration | Office | 30 | 15 | $46.87 | $1,406 |
| 43248 Upper GI Endoscopy | Facility | 29 | 28 | $114.84 | $3,330 |
By year: 2022 $195K for 7,020 services; 2023 $217K for 7,951 services; 2024 $352K for 13,317 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 144 | 68 | $20.48 | $2,949 |
Medicare prescription drug claims, 2024
In 2024, the drug Erik P Thyssen prescribed most often to Medicare patients was Ondansetron Odt (Ondansetron), with 522 prescriptions and refills. In total Erik P Thyssen wrote 1,900 Medicare prescriptions that cost $872K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | 522 | 522 | 490 | $1,203 |
| Omeprazole Generic | 195 | 427 | 68 | $1,881 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 191 | 191 | 189 | $12K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 118 | 118 | 118 | $17K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 54 | 54 | 13 | $1,580 |
| Linzess Linaclotide | 52 | 75 | 17 | $40K |
| Pantoprazole Sodium Generic | 47 | 101 | 17 | $698 |
| Famotidine Generic | 47 | 99 | 16 | $795 |
| Dicyclomine Hcl Generic | 44 | 73 | 12 | $848 |
| Budesonide Ec Budesonide | 38 | 48 | 13 | $5,727 |
| Ciprofloxacin Hcl Generic | 31 | 32 | Under 11 | $745 |
| Budesonide Dr Budesonide | 28 | 45 | Under 11 | $3,266 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 27 | 27 | 26 | $372 |
| Motegrity Prucalopride Succinate | 25 | 25 | Under 11 | $13K |
| Stelara Ustekinumab | 23 | 37 | Under 11 | $552K |
Brand drugs: - claims; generic drugs: 1,429 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Erik P Thyssen $1,288 ($1,288 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $556.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $556 |
| Janssen Biotech, Inc. JNJ | 10 | $373 |
| Genzyme Corporation SNY | 3 | $88.22 |
| Lilly USA, LLC LLY | 3 | $74.99 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $53.56 |
| Micro-tech Endoscopy USA, Inc. | 2 | $38.9 |
| Pfizer Inc. PFE | 2 | $35.09 |
| Madrigal Pharmaceuticals MDGL | 1 | $33.6 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $19.72 |
| QOL Medical, LLC | 1 | $15.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.